contributing factor to the overall complications. The concerns about our very inclusive composite complication rates can be overcome by selecting one's favorite components from Table 3 in the manuscript, which lists all confirmed and suspected infectious complications. The importance of understanding the definition of an infection is exemplified by the study referenced by the authors as having low infection rates, 5 which reported only the rate of prostatitis. It seems implausible that no patient experienced any postbiopsy fever, voiding symptoms, dysuria, other UTIs, or hospital visit.The location of prostate biopsy procedure, ie, in office or in the operating room, is more reflective of local practice patterns and resources. It is unlikely to play a role in reducing infectious complications because the act of inserting needles into the genitourinary tract is an inherently contaminated procedure. Regardless, nearly 3 decades of worldwide experience with the inoffice prostate biopsy would suggest that performing this procedure under sterile conditions is unnecessary and costly.The concern about sepsis rates and sample size of our study is misplaced as our RCT was not designed to study the effect on sepsis rates, but rather on all major and minor infections. Investigators who wish to study sepsis outcomes will need to conduct such a trial, with sepsis as the prespecified outcome. The systematic review by Bennett et al is seductive due to its large population (>165,000 patients). 6 This and other studies are often used by proponents as an example of low sepsis rates after transperineal prostate biopsy while selectively omitting the 4-fold increase in urinary retention or hospital admissions reported in the same studies. 7 A closer examination of that study reveals that the tremendous heterogeneity in the pooled data (technique, prophylaxis, and definitions of outcomes) was such that none of the reported differences in outcomes were statistically significant. Thus, retrospective, heterogenous, observational cohort studies cannot supplant the results of randomized controlled trials.